Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

The maximum human lifespan hasn't moved past 115 years. But is that about to change?

A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Ford rehired roughly 350 veteran engineers to reprogram and retrain artificial intelligence tools used for quality control ...

This week, Ford Motor Company said that it has actually rehired hundreds of veteran human engineers over the past several years after AI failed to match their abilities, and it so ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Contributed by Myles Brown, November 6, 2019 (sent for review July 9, 2019; reviewed by Douglas Yee and Wilbert Zwart) In this study, we integrated FOXA1 cistrome, epigenetic histone marks, and ...

UC San Diego scientists have created a gene therapy that goes beyond masking Alzheimer’s symptoms—it may actually restore brain function. In mice, the treatment protected memory and altered diseased ...

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

Background SIRT6 acts as a tumour suppressor in multiple cancers by regulating glucose and lipid metabolism, but its role in intrahepatic cholangiocarcinoma (ICC) remains unclear. Objective We ...

A longevity startup has dosed its first patient with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug, which the company claims has restored vision in monkeys, for ...